{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-024286","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2023-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.843219+00:00","generated_at":"2026-06-13T09:36:38.189913+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Biofrontera appoints Dr. Heikki Lanckriet to Board under settlement with major stockholder","bullets":["Dr. Heikki Lanckriet appointed to Board of Directors effective July 7, 2023 as Class I director through 2025 annual meeting.","Nominated by Biofrontera AG under April 2023 settlement agreement between the companies.","Compensation: $40,250 annual retainer (pro-rated for 2023) plus annual stock award.","Lanckriet serves as CEO/CSO of 4basebio PLC and on Biofrontera AG's Supervisory Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-024286","json":"https://secwatch.observer/filing/0001493152-23-024286.json","markdown":"https://secwatch.observer/filing/0001493152-23-024286.md","text":"https://secwatch.observer/filing/0001493152-23-024286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223024286/0001493152-23-024286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223024286/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T09:36:38.189913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c98c1b40af","claim":"Heikki Lanckriet was appointed as Director at Biofrontera Inc..","evidence_excerpt":"On July 7, 2023, the board of directors (the “Board”) of Biofrontera Inc. (the “Company”) appointed Heikki Lanckriet to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223024286/0001493152-23-024286-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}